Global Pemetrexed Drug Market Growth (Status and Outlook) 2019-2024

January 2019 | 117 pages | ID: G509D61206EEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.

According to this study, over the next five years the Pemetrexed Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Pemetrexed Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Pemetrexed Drug market by product type, application, key companies and key regions.

This study considers the Pemetrexed Drug value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.

• 100 mg lyophilized powder/vial
• 500 mg lyophilized powder/vial

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.

• Pleural mesothelioma
• Non-small cell lung cancer

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• Eli Lilly and Company
• Pfizer
• Teva
• Eagle Pharmaceuticals
• APOTEX
• Qilu Pharmaceutical
• Biocon
• ...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Pemetrexed Drug market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
• To understand the structure of Pemetrexed Drug market by identifying its various subsegments.
• Focuses on the key global Pemetrexed Drug players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Pemetrexed Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Pemetrexed Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pemetrexed Drug Market Size 2014-2024
  2.1.2 Pemetrexed Drug Market Size CAGR by Region
2.2 Pemetrexed Drug Segment by Type
  2.2.1 100 mg lyophilized powder/vial
  2.2.2 500 mg lyophilized powder/vial
2.3 Pemetrexed Drug Market Size by Type
  2.3.1 Global Pemetrexed Drug Market Size Market Share by Type (2014-2019)
  2.3.2 Global Pemetrexed Drug Market Size Growth Rate by Type (2014-2019)
2.4 Pemetrexed Drug Segment by Application
  2.4.1 Pleural mesothelioma
  2.4.2 Non-small cell lung cancer
2.5 Pemetrexed Drug Market Size by Application
  2.5.1 Global Pemetrexed Drug Market Size Market Share by Application (2014-2019)
  2.5.2 Global Pemetrexed Drug Market Size Growth Rate by Application (2014-2019)

3 GLOBAL PEMETREXED DRUG BY PLAYERS

3.1 Global Pemetrexed Drug Market Size Market Share by Players
  3.1.1 Global Pemetrexed Drug Market Size by Players (2017-2019)
  3.1.2 Global Pemetrexed Drug Market Size Market Share by Players (2017-2019)
3.2 Global Pemetrexed Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PEMETREXED DRUG BY REGIONS

4.1 Pemetrexed Drug Market Size by Regions
4.2 Americas Pemetrexed Drug Market Size Growth
4.3 APAC Pemetrexed Drug Market Size Growth
4.4 Europe Pemetrexed Drug Market Size Growth
4.5 Middle East & Africa Pemetrexed Drug Market Size Growth

5 AMERICAS

5.1 Americas Pemetrexed Drug Market Size by Countries
5.2 Americas Pemetrexed Drug Market Size by Type
5.3 Americas Pemetrexed Drug Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Pemetrexed Drug Market Size by Countries
6.2 APAC Pemetrexed Drug Market Size by Type
6.3 APAC Pemetrexed Drug Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Pemetrexed Drug by Countries
7.2 Europe Pemetrexed Drug Market Size by Type
7.3 Europe Pemetrexed Drug Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pemetrexed Drug by Countries
8.2 Middle East & Africa Pemetrexed Drug Market Size by Type
8.3 Middle East & Africa Pemetrexed Drug Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL PEMETREXED DRUG MARKET FORECAST

10.1 Global Pemetrexed Drug Market Size Forecast (2019-2024)
10.2 Global Pemetrexed Drug Forecast by Regions
  10.2.1 Global Pemetrexed Drug Forecast by Regions (2019-2024)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Pemetrexed Drug Forecast by Type
10.8 Global Pemetrexed Drug Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Eli Lilly and Company
  11.1.1 Company Details
  11.1.2 Pemetrexed Drug Product Offered
  11.1.3 Eli Lilly and Company Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
  11.1.4 Main Business Overview
  11.1.5 Eli Lilly and Company News
11.2 Pfizer
  11.2.1 Company Details
  11.2.2 Pemetrexed Drug Product Offered
  11.2.3 Pfizer Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
  11.2.4 Main Business Overview
  11.2.5 Pfizer News
11.3 Teva
  11.3.1 Company Details
  11.3.2 Pemetrexed Drug Product Offered
  11.3.3 Teva Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
  11.3.4 Main Business Overview
  11.3.5 Teva News
11.4 Eagle Pharmaceuticals
  11.4.1 Company Details
  11.4.2 Pemetrexed Drug Product Offered
  11.4.3 Eagle Pharmaceuticals Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
  11.4.4 Main Business Overview
  11.4.5 Eagle Pharmaceuticals News
11.5 APOTEX
  11.5.1 Company Details
  11.5.2 Pemetrexed Drug Product Offered
  11.5.3 APOTEX Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
  11.5.4 Main Business Overview
  11.5.5 APOTEX News
11.6 Qilu Pharmaceutical
  11.6.1 Company Details
  11.6.2 Pemetrexed Drug Product Offered
  11.6.3 Qilu Pharmaceutical Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
  11.6.4 Main Business Overview
  11.6.5 Qilu Pharmaceutical News
11.7 Biocon
  11.7.1 Company Details
  11.7.2 Pemetrexed Drug Product Offered
  11.7.3 Biocon Pemetrexed Drug Revenue, Gross Margin and Market Share (2017-2019)
  11.7.4 Main Business Overview
  11.7.5 Biocon News

...

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Pemetrexed Drug
Figure Pemetrexed Drug Report Years Considered
Figure Market Research Methodology
Figure Global Pemetrexed Drug Market Size Growth Rate 2014-2024 ($ Millions)
Table Pemetrexed Drug Market Size CAGR by Region 2014-2024 ($ Millions)
Table Major Players of 100 mg lyophilized powder/vial
Table Major Players of 500 mg lyophilized powder/vial
Table Market Size by Type (2014-2019) ($ Millions)
Table Global Pemetrexed Drug Market Size Market Share by Type (2014-2019)
Figure Global Pemetrexed Drug Market Size Market Share by Type (2014-2019)
Figure Global 100 mg lyophilized powder/vial Market Size Growth Rate
Figure Global 500 mg lyophilized powder/vial Market Size Growth Rate
Figure Pemetrexed Drug Consumed in Pleural mesothelioma
Figure Global Pemetrexed Drug Market: Pleural mesothelioma (2014-2019) ($ Millions)
Figure Global Pleural mesothelioma YoY Growth ($ Millions)
Figure Pemetrexed Drug Consumed in Non-small cell lung cancer
Figure Global Pemetrexed Drug Market: Non-small cell lung cancer (2014-2019) ($ Millions)
Figure Global Non-small cell lung cancer YoY Growth ($ Millions)
Table Global Pemetrexed Drug Market Size by Application (2014-2019) ($ Millions)
Table Global Pemetrexed Drug Market Size Market Share by Application (2014-2019)
Figure Global Pemetrexed Drug Market Size Market Share by Application (2014-2019)
Figure Global Pemetrexed Drug Market Size in Pleural mesothelioma Growth Rate
Figure Global Pemetrexed Drug Market Size in Non-small cell lung cancer Growth Rate
Table Global Pemetrexed Drug Revenue by Players (2017-2019) ($ Millions)
Table Global Pemetrexed Drug Revenue Market Share by Players (2017-2019)
Figure Global Pemetrexed Drug Revenue Market Share by Players in 2018
Table Global Pemetrexed Drug Key Players Head office and Products Offered
Table Pemetrexed Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Pemetrexed Drug Market Size by Regions 2014-2019 ($ Millions)
Table Global Pemetrexed Drug Market Size Market Share by Regions 2014-2019
Figure Global Pemetrexed Drug Market Size Market Share by Regions 2014-2019
Figure Americas Pemetrexed Drug Market Size 2014-2019 ($ Millions)
Figure APAC Pemetrexed Drug Market Size 2014-2019 ($ Millions)
Figure Europe Pemetrexed Drug Market Size 2014-2019 ($ Millions)
Figure Middle East & Africa Pemetrexed Drug Market Size 2014-2019 ($ Millions)
Table Americas Pemetrexed Drug Market Size by Countries (2014-2019) ($ Millions)
Table Americas Pemetrexed Drug Market Size Market Share by Countries (2014-2019)
Figure Americas Pemetrexed Drug Market Size Market Share by Countries in 2018
Table Americas Pemetrexed Drug Market Size by Type (2014-2019) ($ Millions)
Table Americas Pemetrexed Drug Market Size Market Share by Type (2014-2019)
Figure Americas Pemetrexed Drug Market Size Market Share by Type in 2018
Table Americas Pemetrexed Drug Market Size by Application (2014-2019) ($ Millions)
Table Americas Pemetrexed Drug Market Size Market Share by Application (2014-2019)
Figure Americas Pemetrexed Drug Market Size Market Share by Application in 2018
Figure United States Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure Canada Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure Mexico Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Table APAC Pemetrexed Drug Market Size by Countries (2014-2019) ($ Millions)
Table APAC Pemetrexed Drug Market Size Market Share by Countries (2014-2019)
Figure APAC Pemetrexed Drug Market Size Market Share by Countries in 2018
Table APAC Pemetrexed Drug Market Size by Type (2014-2019) ($ Millions)
Table APAC Pemetrexed Drug Market Size Market Share by Type (2014-2019)
Figure APAC Pemetrexed Drug Market Size Market Share by Type in 2018
Table APAC Pemetrexed Drug Market Size by Application (2014-2019) ($ Millions)
Table APAC Pemetrexed Drug Market Size Market Share by Application (2014-2019)
Figure APAC Pemetrexed Drug Market Size Market Share by Application in 2018
Figure China Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure Japan Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure Korea Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure Southeast Asia Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure India Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure Australia Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Table Europe Pemetrexed Drug Market Size by Countries (2014-2019) ($ Millions)
Table Europe Pemetrexed Drug Market Size Market Share by Countries (2014-2019)
Figure Europe Pemetrexed Drug Market Size Market Share by Countries in 2018
Table Europe Pemetrexed Drug Market Size by Type (2014-2019) ($ Millions)
Table Europe Pemetrexed Drug Market Size Market Share by Type (2014-2019)
Figure Europe Pemetrexed Drug Market Size Market Share by Type in 2018
Table Europe Pemetrexed Drug Market Size by Application (2014-2019) ($ Millions)
Table Europe Pemetrexed Drug Market Size Market Share by Application (2014-2019)
Figure Europe Pemetrexed Drug Market Size Market Share by Application in 2018
Figure Germany Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure France Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure UK Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure Italy Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure Russia Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure Spain Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Table Middle East & Africa Pemetrexed Drug Market Size by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Pemetrexed Drug Market Size Market Share by Countries (2014-2019)
Figure Middle East & Africa Pemetrexed Drug Market Size Market Share by Countries in 2018
Table Middle East & Africa Pemetrexed Drug Market Size by Type (2014-2019) ($ Millions)
Table Middle East & Africa Pemetrexed Drug Market Size Market Share by Type (2014-2019)
Figure Middle East & Africa Pemetrexed Drug Market Size Market Share by Type in 2018
Table Middle East & Africa Pemetrexed Drug Market Size by Application (2014-2019) ($ Millions)
Table Middle East & Africa Pemetrexed Drug Market Size Market Share by Application (2014-2019)
Figure Middle East & Africa Pemetrexed Drug Market Size Market Share by Application in 2018
Figure Egypt Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure South Africa Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure Israel Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure Turkey Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure GCC Countries Pemetrexed Drug Market Size Growth 2014-2019 ($ Millions)
Figure Global Pemetrexed Drug arket Size Forecast (2019-2024) ($ Millions)
Table Global Pemetrexed Drug Market Size Forecast by Regions (2019-2024) ($ Millions)
Table Global Pemetrexed Drug Market Size Market Share Forecast by Regions
Figure Americas Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure APAC Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Europe Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Middle East & Africa Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure United States Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Canada Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Mexico Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Brazil Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure China Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Japan Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Korea Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Southeast Asia Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure India Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Australia Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Germany Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure France Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure UK Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Italy Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Russia Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Spain Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Egypt Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure South Africa Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Israel Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure Turkey Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Figure GCC Countries Pemetrexed Drug Market Size 2019-2024 ($ Millions)
Table Global Pemetrexed Drug Market Size Forecast by Type (2019-2024) ($ Millions)
Table Global Pemetrexed Drug Market Size Market Share Forecast by Type (2019-2024)
Table Global Pemetrexed Drug Market Size Forecast by Application (2019-2024) ($ Millions)
Table Global Pemetrexed Drug Market Size Market Share Forecast by Application (2019-2024)
Table Eli Lilly and Company Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly and Company Pemetrexed Drug Revenue and Gross Margin (2017-2019)
Figure Eli Lilly and Company Pemetrexed Drug Market Share (2017-2019)
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Pemetrexed Drug Revenue and Gross Margin (2017-2019)
Figure Pfizer Pemetrexed Drug Market Share (2017-2019)
Table Teva Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Pemetrexed Drug Revenue and Gross Margin (2017-2019)
Figure Teva Pemetrexed Drug Market Share (2017-2019)
Table Eagle Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eagle Pharmaceuticals Pemetrexed Drug Revenue and Gross Margin (2017-2019)
Figure Eagle Pharmaceuticals Pemetrexed Drug Market Share (2017-2019)
Table APOTEX Basic Information, Head Office, Major Market Areas and Its Competitors
Table APOTEX Pemetrexed Drug Revenue and Gross Margin (2017-2019)
Figure APOTEX Pemetrexed Drug Market Share (2017-2019)
Table Qilu Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table Qilu Pharmaceutical Pemetrexed Drug Revenue and Gross Margin (2017-2019)
Figure Qilu Pharmaceutical Pemetrexed Drug Market Share (2017-2019)
Table Biocon Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biocon Pemetrexed Drug Revenue and Gross Margin (2017-2019)
Figure Biocon Pemetrexed Drug Market Share (2017-2019)